trending Market Intelligence /marketintelligence/en/news-insights/trending/q9IIVpCc0UNVIa9yv7uRcg2 content esgSubNav
In This List

RXi Pharmaceuticals names board member

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


RXi Pharmaceuticals names board member

RXi Pharmaceuticals Corp. appointed Jonathan Freeman to its board as an independent director, with immediate effect.

Freeman also serves as the chief business officer of privately held Vedanta Biosciences.